Exodus Point Capital Management, LP Cue Biopharma, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$10.86 - $17.85 $180,895 - $297,327	-16,657 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$10.06 - $15.3 $88,528 - $134,640	-8,800 Reduced 34.57%	16,657 $243,000
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.53 $162,410 - $216,497	14,900 Added 141.14%	25,457 $297,000
Q1 2021 May 17, 2021	BUY	$11.2 - $16.09 $118,238 - $169,862	10,557 New	10,557 $129,000
Q3 2020 Nov 16, 2020	SELL	$15.05 - $23.54 $127,428 - $199,313	-8,467 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.7 - $30.73 $107,530 - $260,190	8,467 New	8,467 $208,000

13.8M

56.1K

11.1K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $29M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.